vTv Therapeutics VTVT
NASDAQ VTVT
$30.70 +0.70 (+2.33%)
As of: Sep 30, 2026 · 10:01 AM EDT

vTv Therapeutics (VTVT) Current Debt (2017)

Updated

vTv Therapeutics' Current Debt was $7.5 million in FY2017, down 40.0% from $12.5 million in FY2016.

Analysis

vTv Therapeutics (VTVT) Current Debt (2017) Analysis & Trends

  • Per Business Quant data, Current Debt in earlier years was $12.5 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 vTv Therapeutics 378.73 Mn 378.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 7.50 Mn
API Access

vTv Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=VTVT&period=max&api_key=YOUR_API_KEY